 | • レポートコード：MRC2012A3113 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、エダラボンの世界市場を広く調査・分析し、今後の市場展望をまとめております。エダラボンの種類別市場規模（経口、注射）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Mitsubishi Tanabe Pharma、Sun Pharmaceutical Industries Ltd.、Simcere、Piramal Healthcare、Taj Pharmaceuticals Ltd.、UCB India Ltd、Unichem Laboratories Ltd、 ・地域別グローバル市場分析 2015年-2020年 ・エダラボンの北米市場（アメリカ、カナダ、メキシコ） ・エダラボンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・エダラボンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・エダラボンの南米市場（ブラジル、アルゼンチン） ・エダラボンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Edaravone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Edaravone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Edaravone market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Edaravone market has been segmented into
Oral
Injection
By Application, Edaravone has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Edaravone market presented in the report. This section sheds light on the sales growth of different regional and country-level Edaravone markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Edaravone market.
The report offers in-depth assessment of the growth and other aspects of the Edaravone market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Edaravone Market Share Analysis
Edaravone competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Edaravone sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Edaravone sales, revenue and market share for each player covered in this report.
The major players covered in Edaravone are:
Mitsubishi Tanabe Pharma
Sun Pharmaceutical Industries Ltd.
Simcere
Piramal Healthcare
Taj Pharmaceuticals Ltd.
UCB India Ltd
Unichem Laboratories Ltd
Among other players domestic and global, Edaravone market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Edaravone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Edaravone, with price, sales, revenue and global market share of Edaravone in 2018 and 2019.
Chapter 3, the Edaravone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Edaravone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Edaravone market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Edaravone sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Edaravone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Edaravone Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Edaravone Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Edaravone Market
1.4.1 Global Edaravone Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mitsubishi Tanabe Pharma
2.1.1 Mitsubishi Tanabe Pharma Details
2.1.2 Mitsubishi Tanabe Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Mitsubishi Tanabe Pharma SWOT Analysis
2.1.4 Mitsubishi Tanabe Pharma Product and Services
2.1.5 Mitsubishi Tanabe Pharma Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sun Pharmaceutical Industries Ltd.
2.2.1 Sun Pharmaceutical Industries Ltd. Details
2.2.2 Sun Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sun Pharmaceutical Industries Ltd. SWOT Analysis
2.2.4 Sun Pharmaceutical Industries Ltd. Product and Services
2.2.5 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Simcere
2.3.1 Simcere Details
2.3.2 Simcere Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Simcere SWOT Analysis
2.3.4 Simcere Product and Services
2.3.5 Simcere Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Piramal Healthcare
2.4.1 Piramal Healthcare Details
2.4.2 Piramal Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Piramal Healthcare SWOT Analysis
2.4.4 Piramal Healthcare Product and Services
2.4.5 Piramal Healthcare Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Taj Pharmaceuticals Ltd.
2.5.1 Taj Pharmaceuticals Ltd. Details
2.5.2 Taj Pharmaceuticals Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Taj Pharmaceuticals Ltd. SWOT Analysis
2.5.4 Taj Pharmaceuticals Ltd. Product and Services
2.5.5 Taj Pharmaceuticals Ltd. Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 UCB India Ltd
2.6.1 UCB India Ltd Details
2.6.2 UCB India Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 UCB India Ltd SWOT Analysis
2.6.4 UCB India Ltd Product and Services
2.6.5 UCB India Ltd Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Unichem Laboratories Ltd
2.7.1 Unichem Laboratories Ltd Details
2.7.2 Unichem Laboratories Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Unichem Laboratories Ltd SWOT Analysis
2.7.4 Unichem Laboratories Ltd Product and Services
2.7.5 Unichem Laboratories Ltd Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Edaravone Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Edaravone Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Edaravone Manufacturer Market Share in 2019
3.3.2 Top 6 Edaravone Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Edaravone Sales, Revenue and Market Share by Regions
4.1.1 Global Edaravone Sales and Market Share by Regions (2015-2020)
4.1.2 Global Edaravone Revenue and Market Share by Regions (2015-2020)
4.2 North America Edaravone Sales and Growth Rate (2015-2020)
4.3 Europe Edaravone Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Edaravone Sales and Growth Rate (2015-2020)
4.5 South America Edaravone Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Edaravone Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Edaravone Sales, Revenue and Market Share by Country
5.1.1 North America Edaravone Sales and Market Share by Country (2015-2020)
5.1.2 North America Edaravone Revenue and Market Share by Country (2015-2020)
5.2 United States Edaravone Sales and Growth Rate (2015-2020)
5.3 Canada Edaravone Sales and Growth Rate (2015-2020)
5.4 Mexico Edaravone Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Edaravone Sales, Revenue and Market Share by Country
6.1.1 Europe Edaravone Sales and Market Share by Country (2015-2020)
6.1.2 Europe Edaravone Revenue and Market Share by Country (2015-2020)
6.2 Germany Edaravone Sales and Growth Rate (2015-2020)
6.3 UK Edaravone Sales and Growth Rate (2015-2020)
6.4 France Edaravone Sales and Growth Rate (2015-2020)
6.5 Russia Edaravone Sales and Growth Rate (2015-2020)
6.6 Italy Edaravone Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Edaravone Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Edaravone Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Edaravone Revenue and Market Share by Regions (2015-2020)
7.2 China Edaravone Sales and Growth Rate (2015-2020)
7.3 Japan Edaravone Sales and Growth Rate (2015-2020)
7.4 Korea Edaravone Sales and Growth Rate (2015-2020)
7.5 India Edaravone Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Edaravone Sales and Growth Rate (2015-2020)
7.7 Australia Edaravone Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Edaravone Sales, Revenue and Market Share by Country
8.1.1 South America Edaravone Sales and Market Share by Country (2015-2020)
8.1.2 South America Edaravone Revenue and Market Share by Country (2015-2020)
8.2 Brazil Edaravone Sales and Growth Rate (2015-2020)
8.3 Argentina Edaravone Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Edaravone Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Edaravone Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Edaravone Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Edaravone Sales and Growth Rate (2015-2020)
9.3 Turkey Edaravone Sales and Growth Rate (2015-2020)
9.4 Egypt Edaravone Sales and Growth Rate (2015-2020)
9.5 South Africa Edaravone Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Edaravone Sales and Market Share by Type (2015-2020)
10.2 Global Edaravone Revenue and Market Share by Type (2015-2020)
10.3 Global Edaravone Price by Type (2015-2020)
11 Global Edaravone Market Segment by Application
11.1 Global Edaravone Sales Market Share by Application (2015-2020)
11.2 Global Edaravone Revenue Market Share by Application (2015-2020)
11.3 Global Edaravone Price by Application (2015-2020)
12 Market Forecast
12.1 Global Edaravone Sales, Revenue and Growth Rate (2021-2025)
12.2 Edaravone Market Forecast by Regions (2021-2025)
12.2.1 North America Edaravone Market Forecast (2021-2025)
12.2.2 Europe Edaravone Market Forecast (2021-2025)
12.2.3 Asia-Pacific Edaravone Market Forecast (2021-2025)
12.2.4 South America Edaravone Market Forecast (2021-2025)
12.2.5 Middle East & Africa Edaravone Market Forecast (2021-2025)
12.3 Edaravone Market Forecast by Type (2021-2025)
12.3.1 Global Edaravone Sales Forecast by Type (2021-2025)
12.3.2 Global Edaravone Market Share Forecast by Type (2021-2025)
12.4 Edaravone Market Forecast by Application (2021-2025)
12.4.1 Global Edaravone Sales Forecast by Application (2021-2025)
12.4.2 Global Edaravone Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Edaravone Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Edaravone by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Edaravone Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Mitsubishi Tanabe Pharma Edaravone Major Business
Table 9. Mitsubishi Tanabe Pharma Edaravone Total Revenue (USD Million) (2017-2018)
Table 10. Mitsubishi Tanabe Pharma SWOT Analysis
Table 11. Mitsubishi Tanabe Pharma Edaravone Product and Services
Table 12. Mitsubishi Tanabe Pharma Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Sun Pharmaceutical Industries Ltd. Edaravone Major Business
Table 15. Sun Pharmaceutical Industries Ltd. Edaravone Total Revenue (USD Million) (2017-2018)
Table 16. Sun Pharmaceutical Industries Ltd. SWOT Analysis
Table 17. Sun Pharmaceutical Industries Ltd. Edaravone Product and Services
Table 18. Sun Pharmaceutical Industries Ltd. Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Simcere Basic Information, Manufacturing Base and Competitors
Table 20. Simcere Edaravone Major Business
Table 21. Simcere Edaravone Total Revenue (USD Million) (2017-2018)
Table 22. Simcere SWOT Analysis
Table 23. Simcere Edaravone Product and Services
Table 24. Simcere Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Piramal Healthcare Basic Information, Manufacturing Base and Competitors
Table 26. Piramal Healthcare Edaravone Major Business
Table 27. Piramal Healthcare Edaravone Total Revenue (USD Million) (2017-2018)
Table 28. Piramal Healthcare SWOT Analysis
Table 29. Piramal Healthcare Edaravone Product and Services
Table 30. Piramal Healthcare Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Taj Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Taj Pharmaceuticals Ltd. Edaravone Major Business
Table 33. Taj Pharmaceuticals Ltd. Edaravone Total Revenue (USD Million) (2017-2018)
Table 34. Taj Pharmaceuticals Ltd. SWOT Analysis
Table 35. Taj Pharmaceuticals Ltd. Edaravone Product and Services
Table 36. Taj Pharmaceuticals Ltd. Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. UCB India Ltd Basic Information, Manufacturing Base and Competitors
Table 38. UCB India Ltd Edaravone Major Business
Table 39. UCB India Ltd Edaravone Total Revenue (USD Million) (2017-2018)
Table 40. UCB India Ltd SWOT Analysis
Table 41. UCB India Ltd Edaravone Product and Services
Table 42. UCB India Ltd Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Unichem Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Unichem Laboratories Ltd Edaravone Major Business
Table 45. Unichem Laboratories Ltd Edaravone Total Revenue (USD Million) (2017-2018)
Table 46. Unichem Laboratories Ltd SWOT Analysis
Table 47. Unichem Laboratories Ltd Edaravone Product and Services
Table 48. Unichem Laboratories Ltd Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Edaravone Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Edaravone Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Edaravone Sales by Regions (2015-2020) (K Units)
Table 52. Global Edaravone Sales Market Share by Regions (2015-2020)
Table 53. Global Edaravone Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Edaravone Sales by Countries (2015-2020) (K Units)
Table 55. North America Edaravone Sales Market Share by Countries (2015-2020)
Table 56. North America Edaravone Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Edaravone Revenue Market Share by Countries (2015-2020)
Table 58. Europe Edaravone Sales by Countries (2015-2020) (K Units)
Table 59. Europe Edaravone Sales Market Share by Countries (2015-2020)
Table 60. Europe Edaravone Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Edaravone Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Edaravone Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Edaravone Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Edaravone Sales by Countries (2015-2020) (K Units)
Table 65. South America Edaravone Sales Market Share by Countries (2015-2020)
Table 66. South America Edaravone Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Edaravone Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Edaravone Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Edaravone Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Edaravone Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Edaravone Revenue Market Share by Countries (2015-2020)
Table 72. Global Edaravone Sales by Type (2015-2020) (K Units)
Table 73. Global Edaravone Sales Share by Type (2015-2020)
Table 74. Global Edaravone Revenue by Type (2015-2020) (USD Million)
Table 75. Global Edaravone Revenue Share by Type (2015-2020)
Table 76. Global Edaravone Sales by Application (2015-2020) (K Units)
Table 77. Global Edaravone Sales Share by Application (2015-2020)
Table 78. Global Edaravone Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Edaravone Market Share Forecast by Regions (2021-2025)
Table 80. Global Edaravone Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Edaravone Market Share Forecast by Type (2021-2025)
Table 82. Global Edaravone Sales Forecast by Application (2021-2025)
Table 83. Global Edaravone Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Edaravone Picture
Figure 2. Global Sales Market Share of Edaravone by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Edaravone Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Others Picture
Figure 9. Global Edaravone Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Edaravone Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Edaravone Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Edaravone Sales Market Share by Manufacturer in 2019
Figure 30. Global Edaravone Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Edaravone Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Edaravone Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Edaravone Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Edaravone Revenue Market Share by Regions (2015-2020)
Figure 37. Global Edaravone Revenue Market Share by Regions in 2018
Figure 38. North America Edaravone Sales and Growth Rate (2015-2020)
Figure 39. Europe Edaravone Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Edaravone Sales and Growth Rate (2015-2020)
Figure 41. South America Edaravone Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Edaravone Sales and Growth Rate (2015-2020)
Figure 43. North America Edaravone Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Edaravone Sales Market Share by Countries (2015-2020)
Figure 45. North America Edaravone Sales Market Share by Countries in 2018
Figure 46. North America Edaravone Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Edaravone Revenue Market Share by Countries in 2018
Figure 48. United States Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Edaravone Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Edaravone Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Edaravone Revenue Market Share by Countries in 2019
Figure 54. Germany Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Edaravone Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Edaravone Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Edaravone Revenue Market Share by Regions 2019
Figure 62. China Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Edaravone Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Edaravone Sales Market Share by Countries in 2019
Figure 69. South America Edaravone Revenue Market Share by Countries in 2019
Figure 70. Brazil Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Edaravone Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Edaravone Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Edaravone Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Edaravone Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Edaravone Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Edaravone Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Edaravone Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Edaravone Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Edaravone Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Edaravone Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Edaravone Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Edaravone Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
エダラボンの世界市場（～2026年） Market Analysis and Insights: Global Edaravone Market The global Edaravone market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Edaravone Scope and Market Size Edaravone market is segmented by Type, and by Application. Play…- 筋萎縮性側索硬化症（ALS）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Amyotrophic Lateral Sclerosis (ALS) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 筋萎縮性側索硬化症（ALS）治療薬の世界市場（～2026年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…
- 経口コレラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cholera Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cholera Vaccine mar…
- 糖尿病用注射型ペンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Diabetes Injection Pens market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…